Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov;197(11):1040-1042.
doi: 10.1007/s00066-021-01849-3. Epub 2021 Sep 13.

[A new standard is emerging: PD-1 maintenance therapy after neoadjuvant radiochemotherapy and curative resection of oesophageal and AEG carcinomas (CheckMate 577)]

[Article in German]
Robert Michael Hermann  1 , Hans Christiansen  2
Affiliations
Comment

[A new standard is emerging: PD-1 maintenance therapy after neoadjuvant radiochemotherapy and curative resection of oesophageal and AEG carcinomas (CheckMate 577)]

[Article in German]
Robert Michael Hermann et al. Strahlenther Onkol. 2021 Nov.
No abstract available

PubMed Disclaimer

Comment on

  • Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
    Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lièvre A, Uronis H, Elimova E, Grootscholten C, Geboes K, Zafar S, Snow S, Ko AH, Feeney K, Schenker M, Kocon P, Zhang J, Zhu L, Lei M, Singh P, Kondo K, Cleary JM, Moehler M; CheckMate 577 Investigators. Kelly RJ, et al. N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125. N Engl J Med. 2021. PMID: 33789008 Clinical Trial.

References

Literatur

    1. van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084 - DOI
    1. Ajani JA, Xiao L, Roth JA et al (2013) A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 24:2844–2849 - DOI
    1. Antonia SJ, Villegas A, Daniel D et al (2018) Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. N Engl J Med 379:2342–2350 - DOI
    1. Powles T, Park SH, Voog E et al (2020) Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma. N Engl J Med 383:1218–1230 - DOI
    1. Ascierto PA, Del Vecchio M, Mandalá M et al (2020) Adjuvant nivolumab versus ipilimumab in resected stage IIIB‑C and stage IV melanoma (CheckMate 238): 4‑year results from a multicentre, double-blind, randomised, controlled, phase 3 trial. Lancet Oncol 21:1465–1477 - DOI

Substances

LinkOut - more resources